Docetaxel: In Hormone-Refractory Metastatic Prostate Cancer

By McKeage Kate   Keam Susan J.  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2287-2294

Adis International

Access to resources Recommend Favorite

Docetaxel delivers over doxorubicin for early breast cancer

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

The addition of tesmilifene to mitoxantrone and prednisone reduces pain and prostate-specific antigen levels in patients with painful, hormone-refractory prostate cancer

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Docetaxel in Hormone-Refractory Metastatic Prostate Cancer: A Viewpoint by William R. Berry

By Berry William R.  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2295-2297

Adis International

Access to resources Recommend Favorite

Docetaxel in the management of prostate cancer: current standard of care and future directions

By Dosso Sara De   Berthold Dominik R  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1969-1979

Informa Healthcare

Access to resources Recommend Favorite